4/2
12:17 pm
rhhby
Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis [Yahoo! Finance]
Low
Report
Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis [Yahoo! Finance]
4/2
11:45 am
rhhby
Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis
Medium
Report
Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis
4/1
07:16 am
rhhby
Adams Clinical Site Network Announces Promotion of Dr. Stephanie Rutrick to Chief Medical Officer [Yahoo! Finance]
Low
Report
Adams Clinical Site Network Announces Promotion of Dr. Stephanie Rutrick to Chief Medical Officer [Yahoo! Finance]
3/24
09:22 am
rhhby
3 High-Yield Dividend ETFs to Buy With $500 and Hold Forever [Yahoo! Finance]
Low
Report
3 High-Yield Dividend ETFs to Buy With $500 and Hold Forever [Yahoo! Finance]
3/20
12:27 pm
rhhby
Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025 [Yahoo! Finance]
Low
Report
Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025 [Yahoo! Finance]
3/19
09:00 am
rhhby
NRG Oncology and Flatiron Health announce collaboration to leverage leading technology to drive more efficient clinical trials
Low
Report
NRG Oncology and Flatiron Health announce collaboration to leverage leading technology to drive more efficient clinical trials
3/19
07:01 am
rhhby
Roche abandons global diversity targets on concern over U.S. executive orders [CNBC]
Low
Report
Roche abandons global diversity targets on concern over U.S. executive orders [CNBC]
3/19
06:56 am
rhhby
Roche abandons global diversity targets on concern over U.S. executive orders [Yahoo! Finance Canada]
Low
Report
Roche abandons global diversity targets on concern over U.S. executive orders [Yahoo! Finance Canada]
3/13
03:48 pm
rhhby
Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal [Yahoo! Finance]
Low
Report
Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal [Yahoo! Finance]
3/12
12:37 pm
rhhby
Novo Nordisk Stock Slides After Roche Strikes Weight-Loss Deal [Yahoo! Finance]
Low
Report
Novo Nordisk Stock Slides After Roche Strikes Weight-Loss Deal [Yahoo! Finance]
3/12
10:55 am
rhhby
Novo Nordisk Stock Falls After Roche Strikes Weight-Loss Deal [Yahoo! Finance]
Low
Report
Novo Nordisk Stock Falls After Roche Strikes Weight-Loss Deal [Yahoo! Finance]
3/12
02:42 am
rhhby
Roche pairs with Zealand Pharma on obesity drug candidate [Yahoo! Finance]
Medium
Report
Roche pairs with Zealand Pharma on obesity drug candidate [Yahoo! Finance]
3/12
02:33 am
rhhby
Roche pairs with Zealand Pharma on obesity drug candidate [Yahoo! Finance Canada]
Medium
Report
Roche pairs with Zealand Pharma on obesity drug candidate [Yahoo! Finance Canada]
3/11
08:37 am
rhhby
The first new type of drug for Tourette syndrome in over 50 years is close to the FDA's doorstep [Yahoo! Finance]
Low
Report
The first new type of drug for Tourette syndrome in over 50 years is close to the FDA's doorstep [Yahoo! Finance]
3/5
09:52 am
rhhby
The University of Colorado Cancer Center and Flatiron Health Announce Collaboration to Drive More Efficient Clinical Trials [Yahoo! Finance]
Low
Report
The University of Colorado Cancer Center and Flatiron Health Announce Collaboration to Drive More Efficient Clinical Trials [Yahoo! Finance]
3/5
09:00 am
rhhby
The University of Colorado Cancer Center and Flatiron Health Announce Collaboration to Drive More Efficient Clinical Trials
Low
Report
The University of Colorado Cancer Center and Flatiron Health Announce Collaboration to Drive More Efficient Clinical Trials
3/5
03:17 am
rhhby
FDA accepts supplemental Biologics License Application for Roche's Gazyva/Gazyvaro for the treatment of lupus nephritis [Yahoo! Finance]
Low
Report
FDA accepts supplemental Biologics License Application for Roche's Gazyva/Gazyvaro for the treatment of lupus nephritis [Yahoo! Finance]
3/5
01:51 am
rhhby
FDA Accepts Supplemental Biologics License Application for Genentech's Gazyva for the Treatment of Lupus Nephritis [Yahoo! Finance]
Low
Report
FDA Accepts Supplemental Biologics License Application for Genentech's Gazyva for the Treatment of Lupus Nephritis [Yahoo! Finance]
3/5
01:00 am
rhhby
FDA Accepts Supplemental Biologics License Application for Genentech’s Gazyva for the Treatment of Lupus Nephritis
Low
Report
FDA Accepts Supplemental Biologics License Application for Genentech’s Gazyva for the Treatment of Lupus Nephritis
3/4
04:48 pm
rhhby
Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults [Yahoo! Finance]
Low
Report
Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults [Yahoo! Finance]
3/3
12:44 pm
rhhby
FDA Approves Genentech's TNKase® in Acute Ischemic Stroke in Adults [Yahoo! Finance]
Low
Report
FDA Approves Genentech's TNKase® in Acute Ischemic Stroke in Adults [Yahoo! Finance]
3/3
11:45 am
rhhby
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
Low
Report
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
3/2
05:00 pm
rhhby
Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies
Low
Report
Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies
3/1
05:02 am
rhhby
Amazon Is Trying Physical Retail Again: This Time It’s A Beauty Store In Milan [Forbes]
Low
Report
Amazon Is Trying Physical Retail Again: This Time It’s A Beauty Store In Milan [Forbes]
2/28
04:34 pm
rhhby
Tariffs, Cut Funding Spur Illumina's Worst Month in 23 Years [Yahoo! Finance Canada]
Low
Report
Tariffs, Cut Funding Spur Illumina's Worst Month in 23 Years [Yahoo! Finance Canada]